Stock Markets July 24, 2026 11:53 AM

Options Point to a 4.2% Move for AbbVie Ahead of July 31 Earnings

Implied volatility signals a notable pre-market swing as historical earnings reactions frequently outpaced expectations

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
ABBV

Options market pricing indicates AbbVie Inc. (NYSE:ABBV) could see a 4.2% share-price swing when it reports earnings on July 31 before the market opens, according to Bloomberg options data. Historical outcomes around prior earnings have often exceeded implied moves, with the stock outperforming or underperforming estimated ranges in five of the last eight releases.

Options Point to a 4.2% Move for AbbVie Ahead of July 31 Earnings
ABBV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Options data compiled by Bloomberg put AbbVies implied move at 4.2% for the July 31 earnings release, scheduled before the market opens.
  • In five of the last eight earnings announcements, AbbVies actual share-price moves exceeded the options-implied estimates.
  • Sectors potentially affected include pharmaceuticals and broader equity markets, as a materially sized move in a large drugmaker can influence healthcare peers and pre-market trading dynamics.

Options markets place the implied move for AbbVie Inc. (NYSE:ABBV) at 4.2% for the companys earnings announcement slated for July 31 before the opening bell, according to options data compiled by Bloomberg.

That implied figure provides traders an estimate of the single-day price change the market is pricing in around the earnings event. Over the most recent eight reporting periods, AbbVies actual stock reactions have outstripped the options-implied moves in five instances, underscoring a pattern of bouts of heightened share volatility around results.

A review of the most recent eight earnings-related moves shows the following exact outcomes:

  • April 29, 2026: Options implied a 4.8% move; AbbVie shares fell 0.6%.
  • February 2026: Options implied a 3.8% move; the stock declined 3.0%.
  • October 31, 2025: Shares dropped 4.5% versus an implied move of 3.7%.
  • July 31, 2025: The stock decreased 0.8% compared with an expected 3.5% move.
  • April 25, 2025: Shares climbed 7.6%, exceeding the 5.5% implied move.
  • January 31, 2025: Shares rose 7.8% against a 3.8% expected move.
  • October 30, 2024: The stock advanced 6.7%, above a 3.7% implied move.
  • July 25, 2024: Shares increased 3.9% compared with a 3.6% expected move.

These past outcomes illustrate that implied moves derived from options pricing have not always captured the full extent of AbbVies share-price reactions on earnings days. Some quarters saw the stock move substantially more than the market had priced in, while other quarters produced moves smaller than implied estimates.

For investors and market participants, the 4.2% implied move provides a reference point for setting risk parameters and positioning ahead of the release. Because the earnings report is scheduled before the market opens, the initial price response may be reflected in pre-market trading sessions.

While options-implied moves offer a single-day gauge of expected volatility, the historical record for AbbVie over the eight most recent reports indicates variability in how closely actual outcomes track those expectations.

Risks

  • Implied moves are market expectations, not guarantees; AbbVies actual price change could be materially different, as seen in several prior earnings sessions.
  • Because the earnings release occurs before the market opens, investors may face heightened pre-market volatility and limited liquidity.
  • Historical variability in outcomes means positioning based solely on implied move could misstate potential upside or downside risk for traders and portfolio managers.

More from Stock Markets

Helsinki Index Edges Up as Industrials and Materials Lead Gains Jul 24, 2026 Canadian Solar launches $1 billion heterojunction cell plant in Indiana Jul 24, 2026 Midjourney Expands into Consumer Apps with Acquisition of Co-Star Jul 24, 2026 Tokyo Stocks Slide as Nikkei Falls 2.79% Amid Broad Sector Weakness Jul 24, 2026 Amlogic Shanghai Jumps After H1 2026 Earnings Preview Shows Double-Digit Profit Gain Jul 24, 2026